|
Volumn 89, Issue 5, 2007, Pages 574-579
|
Bone allografts. What they can offer and what they cannot
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GROWTH FACTOR;
RIFAMPICIN;
VANCOMYCIN;
ARTHROPLASTY;
BACTERIUM CONTAMINATION;
BONE ALLOGRAFT;
BONE DEMINERALIZATION;
BONE REMODELING;
CADAVER DONOR;
CANCELLOUS BONE;
CELL DIFFERENTIATION;
DISEASE TRANSMISSION;
DONOR SELECTION;
FEMUR HEAD;
FRACTURE;
FREEZE DRYING;
GRAFT INFECTION;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
INFECTION CONTROL;
INTRAMEDULLARY NAILING;
LIVING DONOR;
OSSIFICATION;
OSTEOBLAST;
OSTEOSYNTHESIS;
PATIENT SAFETY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PSEUDARTHROSIS;
REVASCULARIZATION;
REVIEW;
RISK REDUCTION;
TISSUE PRESERVATION;
TREATMENT FAILURE;
BONE TRANSPLANTATION;
HUMANS;
INFECTION;
ORGAN PRESERVATION;
STERILIZATION;
TISSUE AND ORGAN HARVESTING;
TISSUE DONORS;
|
EID: 34250764370
PISSN: 0301620X
EISSN: None
Source Type: Journal
DOI: 10.1302/0301-620X.89B5.19039 Document Type: Review |
Times cited : (351)
|
References (7)
|